LEONI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 258
NA - Nord America 199
AS - Asia 173
SA - Sud America 3
Totale 633
Nazione #
US - Stati Uniti d'America 197
IT - Italia 145
SG - Singapore 83
HK - Hong Kong 35
FI - Finlandia 34
CN - Cina 30
DE - Germania 27
TR - Turchia 18
CZ - Repubblica Ceca 16
IE - Irlanda 8
GB - Regno Unito 7
PL - Polonia 7
FR - Francia 4
IN - India 4
BE - Belgio 3
CO - Colombia 3
SE - Svezia 3
CA - Canada 2
GR - Grecia 2
ID - Indonesia 1
LK - Sri Lanka 1
NL - Olanda 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
Totale 633
Città #
Singapore 70
Brescia 47
Hong Kong 35
Helsinki 29
Chandler 27
Boardman 22
New York 22
Istanbul 18
Shanghai 16
Brno 15
Munich 13
Barlassina 12
Ashburn 10
Romola 9
Dublin 8
Seattle 8
Milan 7
Fairfield 6
Princeton 6
Wroclaw 6
Rome 5
Lappeenranta 4
Turin 4
Brussels 3
Florence 3
Los Angeles 3
Pune 3
Woodbridge 3
Ann Arbor 2
Athens 2
Bosio 2
Bucaramanga 2
Cetraro 2
Chicago 2
Chiswick 2
Des Moines 2
Halifax 2
London 2
Mazzano 2
Montesilvano Marina 2
Palermo 2
Pavia 2
Pescara 2
San Diego 2
Shijiazhuang 2
Storo 2
Ancona 1
Aosta 1
Bergamo 1
Bogotá 1
Borås 1
Cachan 1
Changchun 1
Chengdu 1
Cleveland 1
Colombo 1
Cremona 1
Fiesole 1
Guangzhou 1
Hounslow 1
Jakarta 1
Malmo 1
Margherita di Savoia 1
North Bergen 1
Prague 1
Ramallah 1
San Francisco 1
Santa Clara 1
Seriate 1
St Petersburg 1
Stockholm 1
Treviglio 1
Warsaw 1
Totale 477
Nome #
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 74
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 58
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 56
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 46
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 44
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 34
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation 34
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 29
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 27
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 27
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 25
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 24
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 24
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 22
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 21
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 21
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 20
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 17
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 16
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 13
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 13
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 9
Totale 654
Categoria #
all - tutte 6.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 3 0 4
2021/202241 0 0 2 0 0 0 5 10 3 9 3 9
2022/2023132 4 1 8 23 8 26 0 12 14 4 16 16
2023/2024284 5 7 16 16 28 49 17 17 39 10 8 72
2024/2025190 8 28 25 72 57 0 0 0 0 0 0 0
Totale 654